Emma Eriksson

2.0k total citations
60 papers, 1.5k citations indexed

About

Emma Eriksson is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Emma Eriksson has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Genetics and 19 papers in Molecular Biology. Recurrent topics in Emma Eriksson's work include Virus-based gene therapy research (21 papers), CAR-T cell therapy research (18 papers) and Cancer Research and Treatments (12 papers). Emma Eriksson is often cited by papers focused on Virus-based gene therapy research (21 papers), CAR-T cell therapy research (18 papers) and Cancer Research and Treatments (12 papers). Emma Eriksson collaborates with scholars based in Sweden, United States and Ireland. Emma Eriksson's co-authors include Angelica Loskog, Leif A. Eriksson, Jessica Wenthe, Gustav Ullenhag, Sandra Irenaeus, Ramón Alemany, Lars Sävendahl, Martı́n E. Rottenberg, Félix Royo and Hans‐Erik Carlsson and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Emma Eriksson

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Eriksson Sweden 23 568 540 416 338 178 60 1.5k
U.A. Ramagopal United States 27 628 1.1× 1.1k 2.0× 1.0k 2.4× 287 0.8× 62 0.3× 53 2.6k
Thierry Rose France 29 167 0.3× 1.2k 2.1× 345 0.8× 332 1.0× 62 0.3× 76 2.2k
Shantanu Sharma United States 21 237 0.4× 981 1.8× 173 0.4× 174 0.5× 70 0.4× 33 1.7k
Pedro José Barbosa Pereira Portugal 29 192 0.3× 1.4k 2.7× 578 1.4× 224 0.7× 125 0.7× 89 2.4k
Andrew J. Beavil United Kingdom 29 304 0.5× 1.1k 2.0× 1.4k 3.3× 378 1.1× 101 0.6× 72 3.1k
Tetsuro Yoshimura Japan 22 351 0.6× 1.4k 2.6× 355 0.9× 130 0.4× 44 0.2× 72 1.9k
Steven M. Chamow United States 26 194 0.3× 1.2k 2.3× 816 2.0× 339 1.0× 166 0.9× 38 2.7k
Vladimir A. Richter Russia 20 175 0.3× 765 1.4× 164 0.4× 160 0.5× 82 0.5× 100 1.4k
Miro Venturi Germany 17 209 0.4× 1.4k 2.6× 604 1.5× 250 0.7× 48 0.3× 24 2.5k
Mohammad Namavari United States 30 538 0.9× 1.4k 2.6× 145 0.3× 1.1k 3.3× 288 1.6× 68 3.4k

Countries citing papers authored by Emma Eriksson

Since Specialization
Citations

This map shows the geographic impact of Emma Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Eriksson more than expected).

Fields of papers citing papers by Emma Eriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Eriksson. The network helps show where Emma Eriksson may publish in the future.

Co-authorship network of co-authors of Emma Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Eriksson. A scholar is included among the top collaborators of Emma Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Eriksson. Emma Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Balodis, M., Manuel Cordova, Albert Hofstetter, et al.. (2024). Atomic-level structure of the amorphous drug atuliflapon via NMR crystallography. Faraday Discussions. 255(0). 342–354. 8 indexed citations
3.
Wenthe, Jessica, et al.. (2024). CD40 stimulation via CD40 ligand enhances adenovirus‐mediated tumour immunogenicity including ‘find‐me’, ‘eat‐me’, and ‘kill‐me’ signalling. Journal of Cellular and Molecular Medicine. 28(7). e18162–e18162. 5 indexed citations
4.
Procopio, Noemi, et al.. (2024). Transferability of Human and Environmental Microbiome on Clothes as a Tool for Forensic Investigations. Genes. 15(3). 375–375. 2 indexed citations
6.
Eriksson, Emma, et al.. (2023). A Comparison of Strategies to Improve Uptake of COVID-19 Vaccine among High-Risk Adults in Nairobi, Kenya in 2022. Vaccines. 11(2). 209–209. 4 indexed citations
7.
Wenthe, Jessica, Rafael Moreno, Gustav Ullenhag, et al.. (2022). Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition. Molecular Therapy — Oncolytics. 24. 429–442. 11 indexed citations
8.
Cordova, Manuel, M. Balodis, Albert Hofstetter, et al.. (2021). Structure determination of an amorphous drug through large-scale NMR predictions. Nature Communications. 12(1). 2964–2964. 55 indexed citations
9.
Wenthe, Jessica, et al.. (2020). Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40. Cancer Gene Therapy. 27(12). 948–959. 39 indexed citations
10.
Eriksson, Emma, Jessica Wenthe, Gustav Ullenhag, et al.. (2017). Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus. Clinical Cancer Research. 23(19). 5846–5857. 116 indexed citations
11.
Wenthe, Jessica, Sara M. Mangsbo, Emma Eriksson, et al.. (2017). Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients. Journal of Translational Medicine. 15(1). 79–79. 37 indexed citations
12.
Eriksson, Emma, Rafael Moreno, Lothar C. Dieterich, et al.. (2016). Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment. Gene Therapy. 24(2). 92–103. 63 indexed citations
13.
Eriksson, Emma, Lokesh Joshi, Martin Billeter, & Leif A. Eriksson. (2014). De novo tertiary structure prediction using RNA123—benchmarking and application to Macugen. Journal of Molecular Modeling. 20(8). 2389–2389. 9 indexed citations
14.
Eriksson, Emma & Leif A. Eriksson. (2012). Identifying the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) as a potential target for hypericin – a theoretical study. Physical Chemistry Chemical Physics. 14(36). 12637–12637. 9 indexed citations
15.
Eriksson, Emma & Leif A. Eriksson. (2011). Predictive power of long-range corrected functionals on the spectroscopic properties of tetrapyrrole derivatives for photodynamic therapy. Physical Chemistry Chemical Physics. 13(15). 7207–7207. 43 indexed citations
16.
Penketh, Philip G., Raymond P. Baumann, Krishnamurthy Shyam, et al.. (2011). 1,2‐Bis(methylsulfonyl)‐1‐(2‐chloroethyl)‐2‐[[1‐(4‐nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a Cytotoxic Prodrug with Two Stable Conformations Differing in Biological and Physical Properties. Chemical Biology & Drug Design. 78(4). 513–526. 9 indexed citations
17.
Eriksson, Emma & Leif A. Eriksson. (2011). Computational design of chlorin based photosensitizers with enhanced absorption properties. Physical Chemistry Chemical Physics. 13(24). 11590–11590. 11 indexed citations
18.
Chagin, Andrei S., et al.. (2009). Catch-up growth after dexamethasone withdrawal occurs in cultured postnatal rat metatarsal bones. Journal of Endocrinology. 204(1). 21–29. 39 indexed citations
19.
Zaman, Farasat, Victoria Menéndez-Benito, Emma Eriksson, et al.. (2007). Proteasome Inhibition Up-regulates p53 and Apoptosis-Inducing Factor in Chondrocytes Causing Severe Growth Retardation in Mice. Cancer Research. 67(20). 10078–10086. 28 indexed citations
20.
Saxena, R.K. & Emma Eriksson. (1985). Hydrometeorological Interpretation of Isotopic Data On Atmospheric Moisture and Precipitation. Annals of Glaciology. 7. 181–184. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026